Robust expansion of antigen-specific peripheral lymphocyte populations through greater proliferation and survival is essential for maintaining effector cell populations at a size sufficient to combat infection. Many pathways can regulate the persistence of activated lymphocytes. For CD4 + T cells, the duration and strength of T cell receptor (TCR) stimulation as well as the expression of costimulatory molecules are all involved in promoting lymphocyte survival [1] [2] [3] , whereas the activation of programmed cell death pathways eliminates activated T cells. Homeostatic regulation of T lymphocyte survival is thought to be mediated mainly by the induction of apoptotic (type I) cell death 4, 5 . Autophagy, a biological process known to promote cellular homeostasis in response to nutrient starvation, is often noted in dying cells and is suggested to be a mechanism of death for a variety of differentiated cell types 6, 7 . Nevertheless, the function of this type II cell death pathway in programmed cell death has been controversial 8, 9 and there is little direct evidence for its participation in the death of activated T lymphocytes 10, 11 .
Although CD4 + T cell effector functions are ultimately linked to the ability of these cells to accumulate at the site of infection and to produce various classes of antimicrobial cytokines, such as IFN-g (A001238), interleukin 4 (IL-4) and IL-17, the effect of the cytokine milieu on CD4 + T cell survival is now appreciated [12] [13] [14] . IFN-g produced by activated T and natural killer cells is essential for host resistance to many bacterial, parasitic and viral pathogens and is also involved in promoting T helper type 1 (T H 1) differentiation. Notably, IFN-g signaling in cultured CD4 + T lymphocytes is also antiproliferative as well as proapoptotic and therefore detrimental for cell survival 15, 16 . Consistent with those in vitro findings, IFN-g-deficient mice have more activated lymphocytes in both infectious and autoimmune disease settings 17, 18 . However, even in the presence of high concentrations of IFN-g produced during T H 1 responses, effector CD4 + T lymphocytes accumulate at sites of infection, which suggests that activated CD4 + T cells have strategies for escaping suppression by IFN-g. Although downregulation of IFN-g receptor expression has been suggested as one mechanism that protects T H 1 lymphocytes from IFN-g-dependent inhibition 19, 20 , this process occurs only in fully differentiated T H 1 cells and thus does not explain how developing T cells survive and proliferate in the presence of autocrine and paracrine IFN-g during early stages of the response.
IFN-g induces the expression of a broad array of genes in both hematopoietic and nonhematopoietic cells. A set of these genes strongly induced by the cytokine encodes the 47-kilodalton GTPase family 21, 22 . One family member, Irgm1 (also called LRG47) is essential for IFN-g-dependent resistance to a wide variety of intracellular bacterial and protozoan pathogens 23 . Although Irgm1 controls the fate of pathogens in IFN-g-activated macrophages by promoting phagolysosome maturation and autophagy 24, 25 , this is not its only function in host resistance. Irgm1-deficient (Irgm1 -/-) mice infected with Mycobacterium avium 26 or Trypanosoma cruzi 27 develop a profound pancytopenia, a defect shown to be associated with impaired expansion of Irgm1 -/-hematopoietic stem and progenitor cell populations 28 . However, these hematopoietic abnormalities are unlikely to be the sole explanation for the rapid development of lymphopenia in infected Irgm1 -/-mice. Mice that undergo thymectomy as adults do not develop a profound depletion in effector CD4 + T cells for a prolonged period after mycobacterial infection 29 , which indicates that the existing peripheral pool can transiently sustain lymphocyte numbers without further input by progenitors. The last observation suggested to us that the lymphopenia of infected Irgm1 -/-mice could also be due to lower survival of mature effector cells.
Here we have addressed the function of Irgm1 in the IFN-gdependent regulation of cell survival in the periphery. Focusing on CD4 + T lymphocytes, we show that IFN-g-induced Irgm1 was critical for the survival of activated mature lymphocytes, as in the absence of Irgm1, IFN-g triggered the death of these cells. Notably, the lymphopenia and mortality noted before in M. avium-infected Irgm1 -/-mice was completely abrogated in mice doubly deficient in both Irgm1 and IFN-g (Irgm1 -/-Ifng -/-mice). Our findings identify an unexpected regulatory function for Irgm1 in lymphocyte survival and suggest that the GTPase is essential for the peripheral expansion of immune effector cell populations during T H 1 responses to intracellular pathogens. Because in our experiments the death of Irgm1 -/-CD4 + T lymphocytes involved an autophagic mechanism rather than an apoptotic mechanism, our findings also identify a previously unknown function for IFN-g-induced autophagy in the programmed cell death of activated T lymphocytes.
RESULTS

Impaired expansion of activated Irgm1 -/-CD4 + T cell populations
To analyze a mature leukocyte population that undergoes extensive proliferation during infection and is involved in host resistance, we focused on the CD4 + T lymphocyte compartment of Irgm1-deficient mice and determined whether mature CD4 + T cells from these mice had defects in proliferation or survival after TCR triggering. We sorted naive wild-type and Irgm1 -/-CD4 + T cells by flow cytometry and stimulated them with agonistic monoclonal antibody (mAb) to CD3 in the presence of irradiated syngenic wild-type splenocytes (Fig. 1a) or, alternatively, with irradiated allogeneic wild-type splenocytes (mixed leukocyte reaction; Supplementary Fig. 1 online) and measured thymidine incorporation 3 d later. We found that Irgm1 -/-CD4 + T cells incorporated less thymidine than wild-type cells did in response to either stimulus. To determine whether Irgm1 -/-CD4 + T cells had similar defects in response to specific antigen, we crossed Irgm1 -/-mice with ovalbumin (OVA) TCR-transgenic OT-II mice to generate Irgm1 -/-OT-II mice. When stimulated with splenic dendritic cells (DCs) pulsed with either OVA protein or a peptide consisting of OVA amino acids 323-339, Irgm1-deficient OT-II cells again incorporated much less thymidine (Fig. 1b) . We then did further experiments to determine whether this impaired thymidine uptake was due to fewer viable T cells or a defect in DNA synthesis. Kinetic studies showed that Irgm1 -/-OT-II cells incorporated less thymidine in response to OVA peptide at all time points analyzed after 24 h (Fig. 1c) and that this defect correlated with a steady decrease in CD4 + T cell numbers in the cultures (Fig. 1d) . However, the Irgm1 -/-cells had unimpaired DNA synthesis, as assessed by incorporation at 72 h of the thymidine analog BrdU at the single-cell level (Fig. 1e) . These lymphocytes also had normal upregulation of CD25 and production of IL-2 (Fig. 1e,f) . Notably, biochemical analysis showed that Irgm1 deficiency did not affect many TCR-dependent signaling events associated with the activation of CD4 + T cells (phosphorylation of tyrosine and the kinase Erk) and survival of CD4 + T cells (degradation of the inhibitor of the transcription factor NF-kB, and phosphorylation of the kinase Akt; Supplementary Fig. 2 online) . In addition, supernatants from peptide-stimulated wild-type OT-II cultures failed to restore the thymidine incorporation of Irgm1 -/-cells, which suggested that this activity did not result from a deficiency in the production or depletion of soluble factors required for T cell population expansion (data not shown). Finally, we noted the Irgm1-dependent defect only after TCR triggering, as Irgm1 -/-lymphocytes were not less viable than wild-type cells when cultured in medium only ( Supplementary Fig. 3a online) . These observations collectively show that although it is dispensable for activation and DNA synthesis, intrinsic expression of Irgm1 is essential for the expansion of CD4 + T lymphocyte populations after TCR stimulation. 
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-/-OT-II Cells (×10 Expansion defect of Irgm1 -/-CD4 + cells is IFN-c dependent Irgm1 expression has been shown to be interferon dependent in most cell types studied before. We found that Irgm1 protein expression in naive wild-type CD4 + T cells stimulated with antibody to CD3 (anti-CD3) and anti-CD28 was inhibited in the presence of mAb to IFN-g (Fig. 2a) , which indicated that induction of the protein in activated CD4 + T lymphocytes required IFN-g. As predicted from that finding, Irgm1 was strongly induced in Irgm1-sufficient T H 1 cells but not T H 2 cells, and its expression in the former T cell subset was maintained for at least 8 d after activation ( Supplementary Fig. 3b ). Although Irgm1 was 'preferentially' expressed in T H 1 cells, Irgm1-deficient CD4 + T cells showed unimpaired IFN-g production in response to OVA peptide in either nonpolarized or T H 1 conditions (Fig. 2b) and showed no defects in T H 1 or T H 2 differentiation in vitro ( Supplementary Fig. 3c ). However, we consistently noted fewer Irgm1 -/-CD4 + T cells than wild-type cells after primary peptide stimulation (Figs. 1 and 2c) and secondary peptide stimulation (Fig. 2d) in nonpolarized or T H 1 conditions (both associated with IFN-g production). In contrast, expansion of OT-II cell populations in T H 2 conditions was minimally affected by Irgm1 deficiency. The failure of the OT-II cells to proliferate after secondary stimulation was not due to impaired cell cycle progression but instead was a consequence of greater death of dividing CD4 + T cells, as shown by experiments in which we labeled cells with both the cytosolic dye CFSE and propidium iodide (Fig. 2e) . The experiments reported above suggested that the survival defect of Irgm1 -/-CD4 + lymphocytes was associated with the presence of IFN-g. We next examined the effect of IFN-g blockade on the survival of activated CD4 + T cells. There was a lower percentage of viable dividing cells in OVA peptide-stimulated Irgm1 -/-OT-II cultures (38%) than in Irgm1-sufficient OT-II cultures (71%). The addition of neutralizing mAb to IFN-g to the Irgm1 -/-OT-II cultures resulted in more dividing cells (71%) with a concurrent decrease in the percentage of dead propidium iodide-positive cells from 27% to 15% (Fig. 2f) . To confirm that finding in a setting in which IFN-g was completely absent, we crossed Ifng -/-and Irgm1 -/-mice to generate mice deficient in both genes. We sorted naive wild-type, Irgm1 -/-, Ifng -/-and Irgm1 -/-Ifng -/-CD4 + T cells and stimulated them with mAb to CD3 in the presence of irradiated Ifng -/-antigenpresenting cells (APCs), then assayed thymidine incorporation 72 h later. We found that in contrast to Irgm1 -/-cells, Irgm1 -/-Ifng -/-CD4 + lymphocytes had unimpaired thymidine uptake similar to the responses of wild-type or Ifng -/-CD4 + T cells (Fig. 2g) . These data collectively establish that IFN-g inhibits the expansion of activated CD4 + T cell populations in the absence of Irgm1.
Because activated Irgm1 -/-Ifng -/-CD4 + T cell populations were able to undergo TCR-driven expansion in vitro, in contrast to IFN-g-sufficient Irgm1 -/-CD4 + T lymphocytes, we were able to assess the function of Irgm1 in the survival of activated CD4 + T cells in vivo. In these experiments, we activated Ifng -/-and Irgm1 -/-Ifng -/-CD4 + T cells (CD45. pathogens known to potently induce IFN-g responses. When we assessed donor CD4 + T cells in the peritoneum (Fig. 3a) and spleen (data not shown) by flow cytometry at 4 d after transfer, we found that although we recovered similar cell numbers from naive recipients, Irgm1-deficient CD4 + T lymphocytes showed lower survival than Irgm1-sufficient cells in recipients infected with either pathogen, This indicated that intrinsic expression of Irgm1 in peripheral CD4 + T cells is required for their survival during pathogendriven T H 1 responses.
Detrimental effects of IFN-c in M. avium-infected Irgm1 -/-mice To test the hypothesis that Irgm1 protects lymphocytes and other cells from the inhibition mediated by IFN-g in vivo, we intravenously infected wild-type, Irgm1 -/-, Ifng -/-and Irgm1 -/-Ifng -/-C57BL/6 mice with M. avium and monitored survival, bacterial loads and hematological responses. Although all Irgm1 -/-mice succumbed to the infection at approximately 40 d after infection, 100% of the Irgm1 -/-Ifng -/-mice survived throughout the course of these experiments (Fig. 3b) . As described before 30, 31 , Ifng -/-mice did not show greater mortality during the same period. Although they were much higher than those of wild-type C57BL/6 mice, the bacterial loads of Irgm1 -/-, Irgm1 -/-Ifng -/-and Ifng -/-mice were indistinguishable (Fig. 3c) , which indicated that the greater mortality of Irgm1 -/-mice could not be explained solely by uncontrolled bacterial infection. Instead, in agreement with published findings 26 , the lower survival of infected Irgm1 -/-mice was associated with considerable lymphopenia as well as a less prominent generalized pancytopenia (Supplementary Table 1 online). Nevertheless, CD4 + T cell activation was unimpaired, as infected wild-type and Irgm1 -/-mice showed similar increases in the percentage of activated CD44 hi CD62L lo CD4 + T cells in spleens before undergoing lymphopenia ( Supplementary Fig. 4 online) . Notably, infected Irgm1 -/-Ifng -/-and Ifng -/-mice did not develop the subsequent decrease in total lymphocyte counts or CD4 + T cell counts (Fig. 3d,e) . These data collectively establish that IFN-g is essential for both the fewer hematopoietic cells and the early mortality of infected Irgm1 -/-mice.
The dependency on IFN-g of the lymphopenia and mortality of M. avium-infected Irgm1 -/-mice that have a T H 1-skewed cellular response suggested that Irgm1 might have only a minimal function in the in vivo host responses to T H 2-inducing helminths when IFN-g production is suppressed 32 . To test that hypothesis, we infected wild-type, Irgm1 -/-, Ifng -/-and Irgm1 -/-Ifng -/-mice with the parasitic trematode Schistosoma mansoni and analyzed host responses at 8 weeks after infection. We found that in contrast to the results obtained after M. avium infection, S. mansoni-exposed Irgm1 -/-mice showed no greater mortality than infected wild-type control mice (Supplementary Fig. 5a online) . Moreover, Irgm1 -/-mice had normal circulating lymphocyte counts ( Supplementary Fig. 5b ) as well as other hematological parameters (data not shown). Notably, schistosome-infected Irgm1 -/-mice had unimpaired granuloma formation and tissue fibrosis, two well characterized T H 2-dependent pathological sequelae of infection 32 . Therefore, these data confirm Irgm1 has no substantial influence on the development of host cellular responses in a T H 2-dominant setting.
IFN-c directly triggers the death of Irgm1 -/-CD4 + T cells
To characterize the mechanism of the IFN-g-dependent suppression of Irgm1 -/-CD4 + lymphocytes, we examined the effects of exogenous IFN-g on the division and death of anti-CD3-activated Ifng -/-and Irgm1 -/-Ifng -/-CD4 + T cells. We used irradiated Ifng -/-APCs in these experiments to completely exclude the possibility of endogenous production of the cytokine. We found that thymidine incorporation by Irgm1 -/-Ifng -/-but not Ifng -/-cells was profoundly inhibited in a dose-dependent way by exogenous IFN-g (Fig. 4a) and this inhibition was associated with fewer cells in the Irgm1-deficient cultures (Fig. 4b) , which indicated that IFN-g directly prevents the accumulation of CD4 + T cells. When we compared the T cell activation, division and viability of the cultures described above at 20 h, before the first cell division, we found that upregulation of CD25 expression and propidium iodide staining were similar in IFN-g-exposed Ifng -/-and Irgm1 -/-Ifng -/-CD4 + T lymphocytes ( Supplementary Fig. 6 online) . This suggested that IFN-g does not inhibit the activation and survival of nondividing Irgm1-deficient cells. After 48 h, Irgm1-sufficient and Irgm1-deficient CD4 + cells underwent similar numbers of divisions in either the presence or absence of IFN-g. However, cell cycle progression in Irgm1 -/-cultures with exogenous IFN-g supplementation was accompanied by larger populations of dead, propidium iodide-positive CFSE + CD4 + T cells, which was evident at 48 h (27%); these cells continued to accumulate and reached about 50% of the total CD4 + T cells by 72 h (Fig. 4c) . Thus, the enhanced death of proliferating cells seemed to be a chief factor limiting the expansion of Irgm1-deficient CD4 + T cell populations in the presence of IFN-g. Consistent with that hypothesis, we noted that previously activated, IL-2-expanded Irgm1 -/-Ifng -/-CD4 + lymphocyte populations were also highly susceptible to IFN-g-induced death (Fig. 4d) . As APCs were not present in the last experimental setting, this observation further confirms a direct function for IFN-g in inhibiting the survival of Irgm1 -/-CD4 + T cells. The greater IFN-g-dependent death of Irgm1 -/-cells could not be explained by augmented cytokine signaling, as we found that the duration and magnitude of phosphorylation of the transcription factor STAT1 in Irgm1-deficient CD4 + T lymphocytes was indistinguishable from that of wild-type cells for either freshly isolated cells ( Supplementary Fig. 7a online) or IL-2-expanded populations ( Supplementary Fig. 7b ). To address whether Irgm1 -/-CD4 + T cells were more sensitive to TCR-induced cell death, we assessed survival of IL-2-expanded CD4 + T cell populations after restimulation with anti-CD3 and found that Irgm1 +/+ and Irgm1 -/-CD4 + cells had similar susceptibility to TCR-induced cell death (Fig. 4e) . In addition, Irgm1-deficient cells had normal expression of the cell surface receptor Fas and its ligand (data not shown) and were not more sensitive to Fasdependent death signals than their wild-type counterparts were in the presence or absence of IFN-g (Fig. 4f) . Therefore, neither TCRinduced cell death nor Fas has a substantial function in the death of IFN-g-treated Irgm1 -/-CD4 + T cells.
Irgm1 prevents the IFN-c-induced autophagic death of CD4 + cells
To investigate the mechanism of the IFN-g-induced death of Irgm1 -/-cells, we used transmission electron microscopy to compare the morphology of IL-2-expanded, activated CD4 + T cell populations from Ifng -/-and Irgm1 -/-Ifng -/-mice after the addition of IFN-g to the APC-free cultures. Although a few Irgm1 -/-cells showed evidence of end-stage apoptotic death, as indicated by condensed chromatin and bleb-like structures, we noted numerous otherwise apparently healthy cells with many more membrane-bound vacuoles closely resembling autophagosomes and autolysosomes in their morphology (Fig. 5a-d) . Some Irgm1 -/-Ifng -/-cells contained many vacuoles of diverse size and electron density (Fig. 5e) , whereas others had a nearly complete absence of cytoplasmic components (Fig. 5f) . We obtained further evidence of autophagosome formation in experiments in which we analyzed the aggregation of microtubule-associated protein 1 light chain 3 in IFN-g-exposed Irgm1 -/-Ifng -/-cells transiently transfected with this protein fused to green fluorescent protein ( Supplementary  Fig. 8 online) . In direct contrast to those observations, which supported the idea of an autophagic death pathway, we found that IFN-g-induced death of Irgm1-deficient cells was not prevented by the addition of the 'pan-caspase' inhibitor z-VAD-fmk (benzyloxycarbonyl-Val-Ala-Asp-fluoromethylketone) or other blockers of apoptotic cell death, including z-LETD-fmk (benzyloxycarbonyl-Leu-GluThr-Asp-fluoromethylketone), z-DEVD-fmk (benzyloxycarbonylAsp-Glu-Val-Asp-fluoromethylketone) and BocD-fmk (t-butoxycarbonyl-Asp-fluoromethylketone; Supplementary Fig. 9a online) . In addition, we noted no reproducible differences in Irgm1 +/+ and Irgm1 -/-cells in their expression of various members of the family of the antiapoptosis protein Bcl-2 (Bax, Bak, Bim, Bid, Bcl2 and Mcl1) with known pro-or antiapoptotic functions in either the presence or absence of IFN-g exposure in vitro (Supplementary Fig. 9b ). In contrast, adding either of the phosphatidylinositol-3-OH kinase inhibitors wortmannin and Ly294002 led to a dose-dependent partial decrease in IFN-g-induced death in Irgm1 -/-cell cultures (Fig. 5g) , which suggested the involvement of phosphatidylinositol-3-OH kinase-dependent autophagy in this process. Because the pharmacological agents used above have inherent toxic effects on the target cells and nonspecifically inhibit other pathways, we further tested the involvement of autophagy by using small interfering RNA to silence the expression of beclin1 (ref. 33 ), a protein required for subcellular membrane condensation during the formation of autophagic vacuoles. We found that whereas knockdown of beclin1 had no effect on the survival of Ifng -/-cells, it resulted in significant prevention of the IFN-g-induced death of Irgm1 -/-Ifng -/-CD4 + T cells (Fig. 5h) .
These findings indicate that in the absence of Irgm1, IFN-g-mediated cell death results mainly from autophagy and this involves a caspaseindependent mechanism distinct from that described before for the IFN-g-dependent death of Igrm1-sufficient CD4 + T lymphocytes 16 .
DISCUSSION IFN-g induces a large array of genes encoding molecules with diverse antimicrobial, antiproliferative and immunomodulatory functions. However, the regulatory mechanisms that determine the beneficial versus detrimental outcomes of the IFN-g response are poorly understood. Here we have shown that Irgm1, which has been characterized as a critical determinant of host resistance to many intracellular bacteria and protozoan agents and as an effector molecule required for macrophage microbicidal activity 24, 25 , has a previously unrecognized function in IFN-g-dependent susceptibility to infection by regulating the sensitivity of activated immune cells to suppression by this cytokine. Because Irgm1 itself is strongly induced by IFN-g, we propose that it provides a positive feedback mechanism in the IFN-g signaling pathway that is designed to prevent the detrimental effects of this cytokine on cell survival while preserving its antimicrobial functions. Our data have also shown the existence of an autophagic death program in lymphocytes that is dependent on IFN-g signaling and is distinct from the autophagic cell death mechanism described before in macrophages, which requires caspase inhibition and induction of the receptor-interacting protein 1 kinase 7, 34 . Irgm1 -/-mice develop profound lymphopenia associated with impaired self-renewal of hematopoietic stem cells after exposure to pathogens 28 , which suggests impairment in lymphocyte replenishment. However, this defect alone cannot fully explain the rapid onset of lymphopenia that occurs in infected Irgm1 -/-mice. We have shown here that depletion of mature effector cells could also contribute to the hematopoietic abnormalities of infected Irgm1 -/-mice. This enhanced cell loss in the periphery may also indirectly contribute to the observed lymphopenia by increasing the mobilization of progenitors from the bone marrow that would exacerbate hematopoietic failure. Therefore, we propose that Irgm1 has a chief function in maintaining lymphocyte homeostasis during host IFN-g responses by promoting the survival of effector cells. This activity of Irgm1 is probably particularly important in the establishment and maintenance of T H 1 responses to persistent intracellular infection. Indeed, we failed to note a similar function in a T H 2-driven infection (S. mansoni) in vivo and T H 2-polarized lymphocyte cultures in vitro. This difference probably reflects the failure of Irgm1 induction in the IFN-g-deficient setting of a T H 2 response. At a more general level, a regulatory mechanism similar to that mediated by Irgm1 may not be necessary for T H 2 responses. Although both IL-4 and IFN-g are important polarizing factors for the differentiation of T helper cells, in contrast to IFN-g, IL-4 does not have the potential to suppress lymphocyte survival but instead serves as a T cell growth factor.
Both indirect and direct mechanisms have been proposed to explain the inhibition of lymphocyte proliferation or survival by IFN-g 14, 16, 18, 35, 36 . An important indirect pathway involves induction by the cytokine in APCs of nitric oxide and/or indoleamine 2,3-dioxygenase, two metabolic products thought to suppress both the cycling and survival of activated T cells 37, 38 . As Irgm1 can shield T lymphocyte responses from IFN-g-mediated inhibition even in the absence of APCs, its main function probably does not involve protection from these reactive metabolites. Instead, the target of Irgm1 regulation is more likely a process that protects T cell from direct inhibition by IFN-g. Previously described mechanisms of this type include the downregulation of IFN-g receptor expression that 
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-/- occurs in differentiated T H 1 cells 19, 20 and the inhibition of IFN-ginduced STAT1 phosphorylation by TCR stimulation 39 . Our observation that STAT1 phosphorylation occurred normally in IFN-g-stimulated Irgm1 -/-CD4 + T cells and was downregulated after TCR engagement (data not shown) challenges the idea of the involvement of those mechanisms. Similarly, although the induction requirements and regulatory activity of Irgm1 resemble those of SOCS1, a known interferon-inducible regulator of IFN-g signaling, Irgm1 seems to exert regulatory functions distinct from those of SOCS1. Thus, whereas both molecules promote host survival by preventing IFN-gdependent pathological responses 40 and are 'preferentially' expressed in T H 1 CD4 + T cells 41 , Irgm1 -/-CD4 + T cells did not show the broad hyper-responsiveness (such as hyperproliferation and dysregulated cytokine production) of their Socs1 -/-counterparts 42 . Moreover, the duration and magnitude of tyrosine phosphorylation of STAT1 was not greater in IFN-g-stimulated Irgm1 -/-CD4 + T cells, in direct contrast to the augmented STAT1 phosphorylation described before in SOCS1 deficiency 43 . Thus, the target of the IFN-g-induced activity of Irgm1 is probably either 'downstream' of STAT1 or involves a signaling pathway independent of the kinase Jak and STAT, such as that mediated by phosphatidylinositol-3-OH kinase 44, 45 . IFN-g can potentiate Fas-dependent TCR-induced cell death in an in vitro model in which the effect of IFN-g is seen during TCR restimulation only in the absence of accessory cells 15 and is dependent on caspase-8 activation 16 . In contrast, as shown here, repeated TCR ligation, a critical step for demonstrating the previously described inhibitory effects of IFN-g on CD4 + T cell survival, was not required for the cytokine-induced death of Irgm1 -/-cells. Furthermore, Irgm1-deficient cells were not more sensitive to Fas-dependent TCR-induced cell death in either the presence or absence of IFN-g. Instead, our study showed Irgm1 exerted its main effects on CD4 + cell survival by regulating IFN-g-dependent autophagic cell death. Although originally recognized as an essential cell survival response to starvation, autophagy has now been shown to have a more general function in maintaining cellular homeostasis 46, 47 . IFN-g is a potent stimulus of autophagy in macrophages and is important in the clearance of pathogens in these cells 25, 48 . In that setting, Irgm1 promotes rather than inhibits autophagy, as noted in the IFN-g-stimulated T cells we studied here. This distinction may reflect the fact that in contrast to CD4 + T cells, macrophages are terminally differentiated nondividing cells in which autophagy is used as a specialized antimicrobial effector mechanism in addition to its more generalized function in cellular homeostasis and survival. Notably, in macrophages, autophagic cell death occurs only when apoptosis is inhibited 7, 34 . In contrast, we found that IFN-g induced autophagic death of Irgm1 -/-CD4 + T lymphocytes in the presence of intact apoptotic machinery. Thus, IFN-g-induced autophagy may have distinct functions in the innate and adaptive immune systems, with Irgm1 as a central regulator of this process exerting either positive or negative effects depending on its cellular context.
Our findings have demonstrated that a single GTPase, Irgm1, can dictate the beneficial outcome of the IFN-g response by providing a feedback mechanism essential for protecting activated CD4 + lymphocytes from IFN-g-mediated death. It should be emphasized, however, that based on published work showing involvement of Irgm1 in regulating the stress response of hematopoietic stem cells, this GTPase probably serves a similar function in other IFN-g-responsive cell lineages. Indeed, we found that the expansion of virus-specific CD8 + T cell populations was considerably impaired in Irgm1 -/-mice infected with lymphocytic choriomeningitis virus (C.G.F. and D.L. Barber, unpublished data). Moreover, generalized effects of Irgm1 on many differentiated leukocyte populations have been noted before, and the restoration of their survival may in part explain the restoration in host resistance noted here in M. avium-infected Irgm1 -/-mice in which IFN-g was also absent. Along with those published findings, our work indicates that Irgm1 serves a series of diverse interferon-dependent functions in the immune response, regulating cellular homeostasis as well as controlling the growth of intracellular pathogens. The common mechanism underlying these distinct activities is unclear at present, although the data presented here suggest the autophagic process as a likely candidate worthy of further investigation.
METHODS
Animals. Wild-type C57BL/6 (CD45.2 + ) and C57BL/6.SJL (CD45.1 + ) mice, as well as Ifng -/-and OT-II TCR-transgenic mice bearing T cells reactive with OVA peptides, were from Taconic Farms (National Institute of Allergy and Infectious Diseases Animal Supply Contract). Irgm1 -/-mice backcrossed more than 12 times to C57BL/6 mice (provided by G. Taylor) were bred and maintained at the animal care facility at the National Institute of Allergy and Infectious Diseases. Irgm1 -/-OT-II mice and Irgm1 -/-Ifng -/-mice were generated by crossing of Irgm1 -/-mice with TCR-transgenic and Ifng -/-mice, respectively. All mice were maintained in specific pathogen-free conditions at an animal facility at the National Institute of Allergy and Infectious Diseases, National Institutes of Health accredited by the American Association for Laboratory Animal Care, under a study proposal approved by the Animal Care and Use Committee of the National Institute of Allergy and Infectious Diseases. Male and female mice between 8 and 12 weeks of age were used.
In vivo infections. Mice were injected intravenously or intraperitoneally with 1 Â 10 6 or 5 Â 10 6 colony-forming units, respectively, of M. avium (strain Sm T 2151), and bacterial loads were quantified as described 26 Leukocyte counts. Lymphocyte numbers in lymphoid organs were calculated by multiplication of viable cell counts by the percentage of lymphocytes determined by flow cytometry according to their forward-and side-scatter parameters. CD4 + T cells were identified with a specific mAb by flow cytometry. Red blood cells, platelets and differential white blood cell counts were made with an automated analyzer using blood obtained from tail tissue in EDTA-containing tubes.
Cell isolation and culture. Flow cytometry-sorted splenic naive CD4 + T cells (B220 -DX5 -I/A -CD62L + CD4 + ) were used in all in vitro experiments. Flow cytometry-sorted splenic DCs (B220 -DX5 -CD11c + ) or irradiated total splenocytes from naive mice (with or without depletion of Thy-1.2 + cells by magnetic beads) were used as APCs. CD4 + cells (5 Â 10 5 cells per ml) were activated with soluble mAb to CD3 (0.5 mg/ml; 145-2C11) or OVA peptide (0.1 mM) in the presence of irradiated splenocytes (2 Â 10 6 cells per ml) or sorted DCs (1.5 Â 10 5 cells per ml) in RPMI-1640 medium supplemented with 10% (vol/vol) heat-inactivated FCS, penicillin (100 U/ml), streptomycin (100 mg/ml), glutamine (2 mM), HEPES (10 mM), pH 7.3, and 2-mercaptoethanol (50 mM). Viable cells of IL-2-expanded populations were enriched by Histopaque (Sigma) before use in secondary restimulation or cell death assays. In some experiments, recombinant cytokines IL-4 (10 ng/ml), IL-12 (10 ng/ml) and IL-2 (10-50 U/ml) as well as mAb to IL-4 (10 mg/ml; 11B11), mAb to IL-12p40 (10 mg/ml; C17.8) and mAb to IFN-g (10 mg/ml; XMG 6) were included. All recombinant cytokines and mAbs were from BD Biosciences. Cell death assay and gene silencing. For cell death assays, CD4 + lymphocytes were activated with anti-CD3 and their populations were expanded with IL-2, then cells were seeded at a density of 2.5 Â 10 5 cells per ml in a 24-well plate and were treated for 24-72 h with IFN-g (5 U/ml), anti-CD3 or Flag-tagged recombinant human CD95 ligand plus anti-Flag (Alexis). Cell viability was assessed by flow cytometry with propidium iodide staining in which all samples were adjusted to equal volume and cells were acquired with a FACSCalibur (BD) at a constant time. Specific cell death was calculated on the basis of propidium iodide-negative live cells as follows: percent cell loss ¼ (1 -treated live cell counts / untreated live cell counts) Â 100. The pharmacological inhibitors wortmannin and Ly294002 were from Calbiochem.
For silencing of the gene encoding beclin1, activated primary CD4 + T lymphocytes were treated for 2 d with IL-2 (50 U/ml) and then were transfected with small interfering RNA with a Mouse T Cell kit and a Nucleofector II device according to the manufacturer's manual (Amaxa). The Stealth small interfering RNA (Invitrogen) had the following sense and antisense sequences: mouse beclin1, 5¢-AGCGGACAGUUUGGCACAAUCAAUA-3¢ and 5¢-UAUUGAUUG UGCCAAACUGUCCGCU; nonspecific, 5¢-AGCGACAGUUUCACGCUAAAG GAUA-3¢ and 5¢-UAUCCUUUAGCGUGAAACUGUCGCU-3¢. Transfected lymphocytes were cultured for 2-4 d in supplemented Mouse T cell Nucleofector medium in the presence of IL-2 (50 U/ml) before further experimentation.
Immunoblot analysis of Irgm1 in primary CD4 + T cells. Lymphocytes were lysed with ice-cold lysis buffer (30 mM Tris-HCl, pH 8, 150 mM NaCl, 2 mM EDTA, 1% (vol/vol) Nonidet-P40, 1% (vol/vol) Triton X-100 and 1Â complete protease inhibitor 'cocktail'; Roche) and Irgm1 protein expression was detected with rabbit polyclonal antiserum as described 26 .
Electron microscopy. Flow cytometry-sorted naive CD4 + T cells were activated and their population were expanded in IL-2 as described above. Viable cells enriched by Histapaque (Sigma) were exposed for 30 h to medium or IFN-g (5 U/ml). Cell fixation and processing for electron microscopy were done as described 49 . Vacuoles were counted by researchers 'blinded' to sample identity.
Additional methods. Information on S. mansoni infection, mixed-leukocyte reactions, biochemical analysis of T cell activation, immunoblot analysis of apoptosis-related molecules and STAT1 phosphorylation and detection of LC3 by immunofluorescence is available in the Supplementary Methods online.
Statistics. The Mann-Whitney test was used to determine the significance of differences between groups. P values of less than 0.05 were considered significant. Accession code. UCSD-Nature Signaling Gateway (http://www.signalinggateway.org): A001238.
Note: Supplementary information is available on the Nature Immunology website.
